1599-5453 Contact Us KO
Diagnostic Tools

Autonomic Testing Protocols

Autonomic Testing Protocols

Autonomic testing protocols are standardized test combinations designed to systematically evaluate the functions of the sympathetic and parasympathetic nervous systems, essential for objective diagnosis and severity grading of autonomic dysfunction.

2026-03-29

At a Glance

Autonomic testing protocols are standardized test systems that comprehensively evaluate various autonomic effector functions including the cardiovascular, sudomotor, and pupillary systems. The Ewing battery is the classic standard, including heart rate variability (HRV), Valsalva maneuver, active standing blood pressure test, head-up tilt test, and sudomotor function test [1]. A minimum combination of three or more tests is performed, providing higher sensitivity and specificity than any single test [2].

Definition and Overview

An autonomic testing protocol is a standardized combination of tests designed to evaluate the functions of the sympathetic and parasympathetic nervous systems in an objective and reproducible manner. Since the autonomic nervous system governs a wide range of functions including cardiovascular, sudomotor, digestive, and genitourinary systems, overall functional status cannot be adequately assessed by a single test alone. Therefore, a test battery that simultaneously evaluates multiple effector systems is necessary [2].

Pre-test Preparation

Patient Preparation

The following guidelines should be observed for accurate test results [5].

  • Minimum 3-hour fasting before testing (water is permitted)
  • No caffeine, nicotine, or alcohol on the day of testing
  • Comfortable clothing, adequate sleep beforehand
  • Examination room temperature maintained at 22-24 degrees C

Medication Discontinuation

Medications affecting the autonomic nervous system should be discontinued for an appropriate period in consultation with the attending physician.

  • Beta-blockers, alpha-blockers: at least 48 hours prior
  • Anticholinergics, antihistamines: at least 48 hours prior
  • Tricyclic antidepressants, SSRIs: 5-7 days prior (with gradual tapering)
  • Midodrine, fludrocortisone: at least 24 hours prior

Standard Test Battery

1. Cardiovascular Parasympathetic Function Tests

#### Heart Rate Variability (HRV)

Resting ECG is recorded to analyze time-domain (RMSSD, pNN50) and frequency-domain (LF, HF, LF/HF ratio) parameters. The HF (0.15-0.40 Hz) component reflects parasympathetic nervous system activity, while the LF/HF ratio indicates sympathetic-parasympathetic balance.

#### Deep Breathing Test

Heart rate fluctuations are measured during deep breathing at 6 breaths per minute. The expiration-to-inspiration heart rate difference (E:I ratio) is a sensitive marker of parasympathetic function. Age-specific normal values exist, with 15 beats/minute or more considered normal and less than 10 beats/minute considered abnormal [1].

#### Valsalva Maneuver

A forced expiratory effort is maintained at 40 mmHg pressure for 15 seconds while observing the four-phase heart rate and blood pressure response (phases I-IV). The Valsalva ratio (maximum heart rate in phase IV / minimum heart rate in phase II) reflects parasympathetic function, with 1.21 or above considered normal [2].

2. Cardiovascular Sympathetic Function Tests

#### Active Standing Test

Blood pressure and heart rate changes are measured upon standing from a supine position. A decrease in systolic blood pressure of 20 mmHg or more, or diastolic blood pressure of 10 mmHg or more within 3 minutes of standing is diagnostic of orthostatic hypotension [3].

#### Head-up Tilt Test

Blood pressure and heart rate changes are monitored for 20-45 minutes while maintaining a passive upright position at 60-70 degrees. This test is essential for the differential diagnosis of vasovagal syncope, POTS, and orthostatic hypotension.

#### Valsalva Maneuver Blood Pressure Response

The four-phase blood pressure response during the Valsalva maneuver is analyzed. Failure of blood pressure recovery in late phase II and loss of the phase IV overshoot suggest sympathetic dysfunction.

3. Sudomotor Function Tests

#### Quantitative Sudomotor Axon Reflex Test (QSART)

Sweating is induced by acetylcholine iontophoresis, and sweat output is measured quantitatively. It is performed at four sites: the forearm, proximal leg, distal leg, and foot. This test is useful for early diagnosis of small fiber neuropathy and autonomic neuropathy [2].

#### Thermoregulatory Sweat Test (TST)

A sweat indicator dye (alizarin red powder) is applied to the entire body, then room temperature is raised to increase body temperature by 1 degree C while observing the distribution of sweating. The pattern of anhidrotic areas helps differentiate central from peripheral lesions.

Results Interpretation

Composite Autonomic Severity Score (CASS)

The Composite Autonomic Severity Score (CASS), developed at Mayo Clinic, quantifies the severity of autonomic dysfunction on a scale of 0 to 10 by summing three subscores: sudomotor (0-3 points), cardiovascular adrenergic (0-4 points), and cardiovascular cholinergic (0-3 points) [2].

  • 0 points: normal
  • 1-3 points: mild dysfunction
  • 4-6 points: moderate dysfunction
  • 7-10 points: severe dysfunction

Clinical Interpretation Patterns

  • Parasympathetic-predominant impairment: decreased deep breathing HRV + reduced Valsalva ratio with normal orthostatic blood pressure suggests early diabetic autonomic neuropathy
  • Widespread autonomic failure: both parasympathetic and sympathetic function impaired + orthostatic hypotension suggests multiple system atrophy or pure autonomic failure
  • Selective sympathetic impairment: sweating abnormalities + orthostatic hypotension with relatively preserved parasympathetic function suggests dopamine beta-hydroxylase deficiency
  • POTS pattern: heart rate increase of 30 bpm or more upon standing without orthostatic hypotension, with possible sweating abnormalities [3]

Limitations of Testing

Autonomic test results are influenced by age, sex, medications, fluid intake, and examination room environment; therefore, tests must be performed under standardized conditions with age-specific normal reference values applied. Furthermore, test abnormalities do not necessarily indicate a specific disease and must be interpreted in conjunction with clinical findings [5].

Frequently Asked Questions

Fast for at least 3 hours before the test and avoid coffee, smoking, and alcohol. Medications that affect the autonomic nervous system (beta-blockers, anticholinergics, antihistamines, etc.) should be discontinued 48 hours to 1 week prior in consultation with your physician to ensure accurate results [5].

The basic test battery (HRV + Valsalva maneuver + standing test) takes approximately 30-45 minutes. Including the tilt table test extends this to approximately 60-90 minutes. Adding sudomotor function tests (QSART, etc.) requires a total of 1.5-2 hours.

Parasympathetic dysfunction most commonly appears in the early stages of diabetic autonomic neuropathy. Sympathetic dysfunction with orthostatic hypotension suggests neurodegenerative conditions such as Parkinson's disease, multiple system atrophy, or pure autonomic failure. POTS shows a pattern of excessive heart rate increase only upon standing [3].

Major indications for autonomic testing include recurrent syncope or dizziness, blood pressure drops or heart rate abnormalities upon standing, unexplained sweating abnormalities, gastrointestinal dysfunction (gastroparesis, constipation), and bladder dysfunction. It is also performed as a routine screening test in diabetic patients [1].

Results from each test are combined to determine the presence, type (sympathetic/parasympathetic), severity (mild/moderate/severe), and distribution (generalized/localized) of autonomic dysfunction. The Composite Autonomic Severity Score (CASS) enables quantification of severity on a scale of 0 to 10 [2].

References

  1. [1] Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985). "The value of cardiovascular autonomic function tests: 10 years experience in diabetes." Diabetes Care, 8: 491-498. DOI PubMed
  2. [2] Low PA (2003). "Testing the autonomic nervous system." Seminars in Neurology, 23: 407-421. DOI PubMed
  3. [3] Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH (2011). "Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome." Clinical Autonomic Research, 21: 69-72. DOI PubMed
  4. [4] Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P (2017). "The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension." Journal of Neurology, 264: 1567-1582. DOI PubMed
  5. [5] Cheshire WP (2019). "Autonomic history, examination, and laboratory evaluation." Continuum (Minneapolis, Minn.), 25: 1134-1142. DOI PubMed

Related Articles

Sudomotor Function Testing
Autonomic TestingAutonomic Function TestingTesting ProtocolsHRVValsalva TestTilt Table TestSudomotor Test

This content is provided for medical information purposes only and cannot replace professional medical advice. If you have symptoms, please consult a specialist.

Are you concerned about related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.

02-514-8887 Contact Us